Back to company

ACUPHARMA ApS: Financial statements 2015

CVR: 10072956

ACUPHARMA ApS (CVR 10072956) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 322,418 and a net result of DKK -359,648 compared with DKK 551,099 the year before. That is a decrease of 77.6% compared with the year before. Equity amounted to DKK 68,286. The solvency ratio was 4.2%.

Gross Profit
322,418 kr.
Profit/Loss
-359,648 kr.
Equity
68,286 kr.
Total Assets
1,624,655 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015-322 t.-360 t.68 t.-
2014-1.4 mio.551 t.773 t.-
2013-574 t.-39 t.222 t.-
2012-365 t.-227 t.261 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2015

ACUPHARMA ApS: The 2014 annual report is outMar 12, 2015

ACUPHARMA ApS has published its annual report for 2014. Gross profit came to DKK 1,441,757, and the net result was DKK 551,099.

Søren Skive leaves the board of ACUPHARMA ApSFeb 10, 2015

As of February 10, 2015, Søren Skive has left the board of directors of ACUPHARMA ApS.

Christina Uekermann Skive leaves the board of ACUPHARMA ApSFeb 10, 2015

As of February 10, 2015, Christina Uekermann Skive has left the board of directors of ACUPHARMA ApS.

Thomas Fog Helsted leaves the board of ACUPHARMA ApSFeb 10, 2015

As of February 10, 2015, Thomas Fog Helsted has left the board of directors of ACUPHARMA ApS.

About ACUPHARMA ApS

ACUPHARMA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christina Uekermann Skive and Jeanne Helsted. The company is owned by SKIVE & HELSTED A/S. The company has 5 employees. In 2025, the company reported a gross profit of DKK 1,150,834 and a net result of DKK 287,572 compared with DKK -258,766 the year before. Equity amounted to DKK -109,301.